Zdrowie i gospodarka · 18/04/2000

Pediatric Parenteral Multivitamin Products; Drug Efficacy Study Implementation; Announcement of Marketing Conditions; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of January 26, 2000 (65 FR 4253). The document announced the conditions for marketing pediatric parenteral multivitamin drug products for the indications for which they are now regarded as effective. The document was published with an inadvertent error. This document corrects that error.